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Abstract: Noise is one of the most common causes of hearing loss in industrial countries. There are
many studies about chemical agents to prevent noise-induced hearing loss (NIHL). However, there is
no commercially available drug yet. Retinoic acid is an active metabolite of Vitamin A; it has an
anti-apoptic role in NIHL. This study aims to verify the differences among selective agonists of
retinoic acid receptors (RARs) in NIHL. All-trans retinoic acid (ATRA), AM80 (selective retinoic acid
receptor α agonist), AC261066 (Selective retinoic acid receptor β1 agonist), and CD1530 (Selective
retinoic acid λ agonist) were injected to 6–7 weeks old CJ5BL/6 mice before noise (110 dB for 3 h)
exposure. In the auditory brainstem response test pre-, post 1, 3, and 7 days after noise exposure,
not only ATRA but all kinds of selective RAR agonists showed protective effects in hearing threshold
and wave I amplitude. Though there was no significant difference in the level of protective effects
between agonists, α agonist showed the most prominent effect in preserving hearing function as
well as outer hair cells after noise exposure. In conclusion, selective agonists of RAR demonstrate
comparable protective effects against NIHL to retinoic acid. Given that these selective RAR agonists
have less side effects than retinoic acid, they may be promising potential drugs against NIHL.
Keywords: Noise-induced hearing loss; sensorineural hearing loss; retinoic acid; selective
RAR agonists
1. Introduction
Noise-induced hearing loss (NIHL) is a common form of hearing loss inin industrial countries.
In particular, enhanced exposure to noise in work places can result in hearing loss. The number of
patients with NIHL has greatly increased, making it a significant public health problem. The World Health
Organization estimates that 1.1 billion young people worldwide could be at risk of hearing loss [1].
The mechanisms of NIHL comprise both direct mechanical damage and metabolic damage.
Excessive noise can cause damage to middle ear structures, round and oval window membranes, and the
organ of Corti. The outer hair cells of the cochlea are highly vulnerable to noise exposure. Noise can
distort the stereocilia of hair cells, causing defects in mechanotransduction. Free radicals (e.g., reactive
oxygen species) can damage the cell membrane through necrosis or apoptosis of neighboring cells [2].
Several compounds have been developed to protect against NIHL; however, there is no
commercially available drug yet. Retinoic acid (RA), an active metabolite of vitamin A, enables
hearing recovery in mouse models of NIHL. RA can inhibit the JNK pathway of apoptosis [3], which is
activated in stressed inner ear cells [4]. Another study has shown that RA-induced peroxiredoxin
6 expression can contribute to recovery from noise-induced temporary hearing threshold shift [5].
RA plays various roles in cell induction, differentiation, and development [6]; RA binds to RA receptors
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(RAR) and retinoid x receptors (RXR), both of which serve as potential therapeutic targets in the inner
ear. RAR α and λ transcripts are found in the organ of Corti and the spiral ganglion whereas RAR
β1 transcripts are found in mesenchymal-derived tissue in the inner ear of mice [7]. Notably, RAR α
and λ are required for inner ear development and have an essential role in the initial differentiation in
mice [8].
In this study, we examined the effect of selective administration of RAR agonists to prevent NIHL.
2. Materials and Methods
2.1. Animals
C57BL/6 mice (6–7 weeks old; Orient Bio, GyeongGi province, Korea) were housed and maintained
according to the Yonsei University Health System animal research requirements; all procedures were
approved by the Yonsei University Health System Institutional Animal Care and Use Committee
(IACUC Approval Number 2017-0181). Mice were fed ad libitum and housed in cages in an
environmentally controlled room under a 12-h light cycle. A total of 40 mice were used, 8 mice
per group, randomly distributed.
2.2. Noise Generation
White noise (300–10,000 Hz) was generated by a personal computer and an amplifier (R-399,
Inter M, Seoul, Korea) and delivered through speakers (290-8L, Altec Lansing, Oklahoma City, OK,
USA) in a noise booth. Mice were continuously exposed to 110 dB peak equivalent SPL for one 3-h
session. It was considered that noise exposure of 110 dB SPL for 3 h is reasonable to induce NIHL
based on a review of the literature [5,9].
2.3. All-Trans Retinoic Acid (ATRA) and Selective RAR Agonist Treatment
ATRA, AM80 (RAR α agonist), AC261066 (RAR β1 agonist), CD1530 (RAR λ agonist),
and dimethylsulfoxide (DMSO, control) were used to prevent cochlear damage during noise exposure.
They were all dissolved in DMSO at final concentrations of 20 mmol. ATRA and each selective agonist
were administered to mice 1 day before noise exposure and 2 h before noise exposure via intraperitoneal
(IP) injection. The control groups underwent IP injection of DMSO or water ( 60 µL).
2.4. Audiologic Evaluation
The hearing level of each mouse was checked by measuring the auditory brainstem response (ABR)
threshold with a TDT auditory evoked potential workstation (Tucker-Davis Technologies, Alachua, FL,
USA) as described previously [10]. Mice were anesthetized by IP injection of ketamine hydrochloride
(30 mg/kg) and xylazine (2 mg/kg). Both ears of each mouse were stimulated with an ear probe sealed
in the ear canal. The ABRs to click and tone stimuli were recorded, and thresholds were obtained for
each ear. ABRs were measured before noise exposure, immediately after noise exposure, 2 days after
noise exposure, and 6 days after noise exposure.
2.5. Cochlear Cell Survival
One week after noise exposure, mice were euthanized with CO2 gas and the cochlea was quickly
removed from each mouse. A whole mount preparation of the cochlea was performed. All cochlear
tissues were separated into apical, middle, and basal turns. After dissection, middle turn was
immunostained with fluorescently tagged antibodies. The rabbit myosin 7a antibody was used
as primary antibody to stained cochlear hair cells, and 4′,6-diamidino-2-phenylindole (DAPI) was
used to counterstain nuclei. All cochlear turns were examined under a Zeiss LSM 700 confocal
microscope [10,11]. Outer hair cells were counted and compared between groups.
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2.6. Statistics
Statistical analyses of ABR threshold shift between groups were performed with the Kruskal-Wallis
and Mann-Whitney tests for comparisons between pairs of groups, using IBM SPSS Statistics for
Windows, Version 22.0 (Armonk, NY, USA) and GraphPad Prism (Version 5) (La Jolla, CA, USA).
Differences between mean values were considered statistically significant at p < 0.05.
3. Results
All five groups demonstrated healthy hearing thresholds before noise exposure. After noise
exposure, the control group (DMSO injection via IP) showed 92.1 ± 16.8 dB of hearing loss in
click-evoked ABR, with an elevated hearing threshold immediately after noise exposure. The ABR
thresholds of ATRA-treated and RAR agonist-treated mice were lower than those of the control group;
there was a statistically significant difference in click-evoked ABR (Figure 1).
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Fig re 1. a ges i click-e oke a itory brai ste res o se ( ) t res ol . re i icates before
noise expos re, ay 1 is i e iately after noise expos re. here as a significant ifference a ong
the groups i ediately after noise exposure. * p 0.05.
Figure 2 shows the ABR thresholds of all groups at day 1, 3, and 7. The ATRA-injected group
showed 65.0 ± 22.1 dB of hearing loss; the AM80-injected group showed 58.6 ± 9.1 dB of hearing
loss; the AC261066-injected group showed 64.6 ± 20.4 dB of hearing loss; and the CD1530-injected
group showed 62.9 ± 23.1 dB of hearing loss. In tone-evoked ABR especially, hearing threshold was
lower at low frequencies, 4000 and 8000 Hz, which indicates that the protective effects of RAR agonists
mostly affect high frequencies. At day three, threshold shift in ABR showed recovery in five groups;
this recovery differed among control, ATRA-treated, and RAR agonist-treated groups, but the statistical
evidence for this difference was weak. At day seven, the control group showed partial recovery of
ABR threshold, 50.8 ± 20.5 dB of hearing loss. All RAR agonist-treated groups showed recovery from
noise exposure.
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Figure 2. Click-evoked auditory brainstem response (ABR) thresholds immediately after noise exposure
at Day 1 (A), 3 (B) and 7 (C). The hearing thresholds were significantly lower in groups treated with
all-trans retinoic acid (ATRA) and all selective retinoic acid receptor (RAR) agonists than in the control
group at every frequency, especially high frequency at Day 1(A). (p < 0.05) ABR thresholds began to
recover in all groups at Day 3 and Day 7.
We also examined the amplitude of wave I in ABR. As seen in Figure 3, the amplitude of wave I
was significantly higher in the treatment groups with RAR agonists (AM80 and CD1530) compared to
the control group after noise exposure (Figure 3A,B).
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Figure 3. Comparison of wave I amplitude in auditory brainstem response (ABR). In click-evoked ABR
(80 dB HL sti ulus), wave I amplitude from P1 to N1 was acquired (A). The amplitude of wave I was
significantly higher in the groups treated with ATRA and RAR agonists than the control group ne day
after noise exposure (B). Statistical analysis was performed with the reference value of lane 1. * p < 0.05.
Next, hair cell survival was examined at 1 week after noise exposure (Figure 4A). Whole mount
preparations of the middle turn of cochlea were performed and examined by confocal microscopy.
In the control group, 88.94% of cochlear outer hair cells survived at the middle turn. The RAR
agonist- reated groups showed signifi antly b tt r oute hair cell survivals (Figure 4B). The summary
of data were described in Table 1.
Int. J. Environ. Res. Public Health 2019, 16, 3428 5 of 8
Int. J. Environ. Res. Public Health 2019, 16, x 5 of 8 
 
Figure 4. Effect of all-trans retinoic acid (ATRA) on hair cell damage after noise exposure. (A) Day 7, 
whole mount preparation of the cochlea was performed. Hair cells were stained with 4′,6-diamidino-
2-phenylindole (DAPI; blue) and Myosin 7a (green), and observed under a confocal microscope (scale 
bar, 20 µm). Images of middle turn of cochlea, control group showed damaged outer hair cells, 
whereas the selective retinoic acid receptor (RAR) agonist groups showed preserved outer hair cells. 
(B) Outer hair cell survival rate in each group was compared (n = 6–10). Scale bars, 10 µm. Statistical 
analysis was performed with the reference value of lane 1. *** p < 0.001, ** p < 0.01, * p < 0.05. 
Table 1. The preventive effects of retinoic acid receptor agonists on noise-induced hearing loss. 
Compounds 
Hearing Threshold  
(dB SPL) 
Wave I Amplitude  
(nV) 
Hair Cell Survival  
(%) 
Control 92.1 ± 16.8 143.2 ± 365.9 88.2 ± 7.6 
ATRA 65.0 ± 22.1 * 471.7 ± 455.7 99.7 ± 1.1 *** 
AM80 58.6 ± 9.1 * 637.5 ± 515.7 * 97.4 ± 2.5 * 
AC261066 64.6 ± 20.4 * 538.1 ± 452.2 96.5 ± 6.1 * 
CD1530 62.9 ± 23.1 * 587.4 ± 561.5 * 97.3 ± 3.4 ** 
Hearing threshold and wave I amplitude are the results from auditory brainstem response by click 
stimulation in post-noise 1 day. Statistical analyses were performed in comparison to the control 
group. * p < 0.05; ** p < 0.01; *** p < 0.001. 
4. Discussion 
Noise-induced hair cell damage is critical in that it results in temporary or permanent hearing 
loss. In mammals, damaged hair cells are difficult to regenerate; once a permanent threshold shift has 
developed, it cannot be repaired. Studies regarding RA treatment for NIHL have shown preservation 
of hearing in mouse models of permanent and temporary threshold shift. Previous studies have 
revealed that noise exposure induces the JNK pathway in inner ear cells. JNK is a protein kinase 
activated by cellular stress; it activates phosphorylation of c-Jun, which mediates the initiation of 
apoptosis. RA inhibits the induction of JNK, leading to the inhibition of apoptosis in the inner ear 
hair cells [3,5]. 
A recent study showed ATRA-induced peroxiredoxin 6 (Prdx6)-associated recovery from NIHL. 
Increased expression of Prdx6 protects cells from membrane damage associated with peroxidation 
ATRA AM80
AC261066 CD1530
Control
A
B
C
o
n
tr
o
l
A
T
R
A
A
M
8
0
A
C
2
6
1
0
6
6
C
D
1
5
3
0
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
H
a
ir
 c
e
ll
 s
u
r
v
iv
a
l 
 (
%
)
*** * * **
Figure 4. Effect of all-trans retinoic acid (ATRA) on hair cell damage after noise exposure.
(A) Day 7, whole mount preparation of the cochlea was performed. Hair cells were stained with
4′,6-diamidino-2-phenylindole (DAPI; blue) and Myosin 7a (green), and observed under a confocal
microscope (scale bar, 20 µm). Images of middle turn of cochlea, control group showed damaged outer
hair cells, whereas the selective retinoic acid receptor (RAR) agonist groups showed preserved outer
hair cells. (B) Outer hair cell survival rate in each group was compared (n = 6–10). Scale bars, 10 µm.
Statistical analysis was performed with the reference value of lane 1. *** p < 0.001, ** p < 0.01, * p < 0.05.
Table 1. The preventive effects of retinoic acid receptor agonists on noise-induced hearing loss.
Compounds Hearing Threshold (dB SPL) Wave I Amplitude (nV) Hair Cell Survival (%)
Control 92.1 ± 16.8 143.2 ± 365.9 88.2 ± 7.6
ATRA 65.0 ± 22.1 * 471.7 ± 455.7 99.7 ± 1.1 ***
AM80 58.6 ± 9.1 * 637.5 ± 515.7 * 97.4 ± 2.5 *
AC261066 64.6 ± 20.4 * 538.1 ± 452.2 96.5 ± 6.1 *
CD1530 62.9 ± 23.1 * 587.4 ± 561.5 * 97.3 ± 3.4 **
Hearing threshold and wave I amplitude are the results from auditory brainstem response by click stimulation in
post-noise 1 day. Statistical analyses were performed in comparison to the control group. * p < 0.05; ** p < 0.01;
*** p < 0.001.
4. Discussion
Noise-induced hair cell damage is critical in that it results in temporary or permanent hearing
loss. In mammals, damaged hair cells are difficult to regenerate; once a permanent threshold shift has
devel ped, it cannot be repaired. Studies egardi g RA treatment for NIHL have shown pr servatio of
heari g in mouse models of pe manent and temporary threshold shift. Previous studi have revealed
that noise exposure induces the JNK pathw y i inner ear cells. JNK is a protein kinase activated by
cellular stress; it activates ph sphorylation of c-Jun, which mediates the initiation of apoptosis. RA
inhibits t e induction of JNK, leading to the inhibition of apoptosis in the inner ear hai c lls [3,5].
A recent st dy showed ATRA-induced eroxired xin 6 (Prdx6)-associated r covery from NIHL.
Increa ed expression of Prdx6 protects cells from membrane damage associated with peroxidation [5].
Increased Prdx6 protein expression was observed early after noise exposure; it remained elevated for
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24 h. The RAR-related orphan receptor α1 is associated with Prdx 6 expression. RAR α functions as
a transactivator of Prdx6 gene expression. These findings suggest that selective RAR agonists have
specific roles, which differ among each other.
Our results also suggest that temporary noise exposure not only damages hair cells but also
decreases auditory neuronal responses, which is referred to as amplitude in wave I in ABR. Decreased
amplitude of wave I in ABR after noise exposure is consistent with the previous result that cochlear
synaptopathy and the followed cochlear nerve degeneration is associated with temporary NIHL [12,13].
Although hearing threshold in ABR is completely recovered after temporary noise exposure, there
is still a decrease in synaptic vesicles in inner hair cells and it may cause hidden hearing loss, which
is a potential risk factor for age-related hearing loss in the later. Notably, the present data show that
ATRA and selective RAR agonists ameliorate decrease in wave I amplitude in ABR. In this regard,
ATRA or selective RAR agonists could be a potential target for the prevention of NIHL after temporary
noise exposure.
As mentioned above, RAR distribution in the developing inner ear is quite different. RAR α is
predominantly expressed in the developing sensory epithelium, RAR β in inner ear mesenchymal
tissues, and RAR γ in the differentiating otic capsule. In an adult mouse, RAR α and RAR γ transcripts
are found in the organ of Corti and the spiral ganglion, whereas RAR β transcripts are localized in
mesenchyme-derived tissues. However, our result showed no differences between RAR agonist-treated
groups. All selective RAR agonists can protect hair cell from noise, especially at high frequencies.
There were no statistical differences at Day 7 of the experiment (6 days after noise exposure). We
assume that it was a result of small sample size and unexpected loss of mice during the experiment.
We performed IP injection with dissolved agonists in DMSO. DMSO is a well-known solvent that can
solubilize a wide variety of molecules. We also confirmed that DMSO did not have any effects to
cochlea, by comparing with water injected group to rule out placebo effect. There was no difference
between water and DMSO groups in ABR threshold, wave I amplitude and hair cell survival rate
(Supplementary Figure S1). However, there have been reports regarding the unexpected low-dose
toxicity of DMSO [14,15]. During our experiments, some mice were lost in both control and agonist
groups for unknown reasons.
Our data did not show any differences between selective RAR agonists; however, other studies have
shown that selective RAR agonists can serve as therapeutic options in many diseases. Selective RAR α
agonists have therapeutic potential for the treatment of immune diseases, cancer, and Alzheimer’s
disease [16]. Selective RAR α agonists have shown inhibition of tumor proliferation, as well as
induction of tumor cell apoptosis, in murine models [17]. In T-cell lymphoma, RAR α overexpression
augmented chemosensitivity to retinoids and AM80 administration inhibited cell growth, which may
indicate a therapeutic target in some peripheral T-cell lymphomas [18]. In addition, the selective
RAR α agonist AM80 showed a neuroprotective effect in a mouse model of intracerebral hemorrhage.
AM80 decreased activation of macrophages affected by oxidative stress. Treatment with AM80 also
decreased the area of nitrotyrosine immunoreactivity [19]. Another study showed that nitrotyrosine
immunoreactivity can be induced by noise; notably, increased nitrotyrosine expression in outer hair
cells caused apoptosis in a guinea pig model [20]. Therefore, it is highly possible to apply selective
RAR α agonist against NIHL.
5. Conclusions
RA and selective RAR agonists exert protective effects in NIHL, such that outer hair cells are
preserved. Given that most of the environmental noise are in the level of transient threshold shift,
we considered that retinoic acid receptor agonists could be utilized to prevent transient shift and relieve
the related tinnitus symptom. Regardless of differences among RAR agonists, they all demonstrate
protective effects, especially during exposure to high-frequency noise, and may serve as therapeutic
agents for NIHL.
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Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/16/18/3428/s1.
Figure S1: Data from placebo group with water (n = 3) was compared with that from placebo group with DMSO
(n = 3). A. in post-noise day 7, wave I amplitude in auditory brainstem response (ABR) did not differ between
two groups. B. ABR threshold by click stimuli after noise exposure were not significantly different between two
groups over time.
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